Stegmayr B, Granbom L, Karlsson U M, Lindqvist B
Department of Internal Medicine, University Hospital, Umeå, Sweden.
Adv Perit Dial. 1993;9:62-4.
This study was performed to evaluate the use of the glucose concentration versus glucose absorption in the dialysate to estimate ultrafiltration efficacy. In 26 patients (16 men, 10 women) on continuous ambulatory peritoneal dialysis, a total of 128 dwells were investigated. Each dwell lasted 5 hours, using 2 L of peritoneal dialysis fluid containing 140 mmol/L glucose. After the dwell, the removed peritoneal dialysis fluid was weighted. The concentrations of creatinine and glucose and the total amount of glucose were analyzed. The mean concentration of dialysate glucose for the whole group after a 5-hour dwell was 38.9 +/- 8.9 (SD) mmol/L. The ultrafiltration volume was inversely correlated to the glucose absorbed (r = -0.59, p = 0.002), but was not significantly correlated to the glucose concentration in the dialysate (r = 0.40, p = 0.057). The ultrafiltration volume was not related to the creatinine concentration in the dialysate or the body weight. The average dialysate glucose did not change during a one-year observation time. Patients with diabetes mellitus had significantly lower glucose absorption than nondiabetics (p = 0.045), and patients with low ultrafiltration efficacy had significantly greater glucose absorption than those with normal and high ultrafiltration (p = 0.038). There was no difference between those who had those who had not suffered from peritonitis. The results indicate that the glucose absorption from the dialysis fluid is the best parameter to calculate the peritoneal ultrafiltration efficacy and not the glucose concentration currently used.
本研究旨在评估利用透析液中的葡萄糖浓度与葡萄糖吸收量来估计超滤效果。对26例持续非卧床腹膜透析患者(16例男性,10例女性)共进行了128次透析观察。每次透析持续5小时,使用2L含140mmol/L葡萄糖的腹膜透析液。透析结束后,对排出的腹膜透析液进行称重,并分析其中肌酐、葡萄糖的浓度以及葡萄糖总量。5小时透析后,全组透析液葡萄糖平均浓度为38.9±8.9(标准差)mmol/L。超滤量与葡萄糖吸收量呈负相关(r = -0.59,p = 0.002),但与透析液中葡萄糖浓度无显著相关性(r = 0.40,p = 0.057)。超滤量与透析液中肌酐浓度或体重无关。在一年的观察期内,透析液葡萄糖平均浓度无变化。糖尿病患者的葡萄糖吸收量显著低于非糖尿病患者(p = 0.045),超滤效果差的患者葡萄糖吸收量显著高于超滤正常和超滤效果好的患者(p = 0.038)。有无腹膜炎患者之间无差异。结果表明,计算腹膜超滤效果的最佳参数是透析液中的葡萄糖吸收量,而非目前使用的葡萄糖浓度。